Product Information

BUDESONIDE ER 9 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $15.0801 per EA under NDC 00378450093. Its NADAC has been published 311 times since Dec 9, 2020.

FDA first approved this application on Sep 17, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUDESONIDE ER 9 MG TABLET

Budesonide
$15.0801per EA

Strength

9 mg/1

NDC

00378450093

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

BUDESONIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA208851

FDA Approved

9/17/2020

TE Code

AB

On Market Since

10/21/2020

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for BUDESONIDE ER 9 MG TABLET has been published 311 times since Dec 9, 2020, and over the history we have for it it has declined 57.4%. The table below summarizes its recorded NADAC range and movement.

Current price$15.0801 per EA
All-time high$40.3126 (Jan 13, 2021)
All-time low$11.9909 (May 20, 2026)
52-week high$18.6414
52-week low$11.9909
Median price$26.4179
Average price$25.0299
Largest weekly change-35.3% (Apr 17, 2024)
Weeks tracked311
Tracking sinceDec 9, 2020

Price History

1W

-2.3%

1M

-3.0%

3M

-9.1%

6M

+25.8%

1Y

+12.7%

3Y

-54.9%

5Y

-47.7%

All

-57.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUDESONIDE ER 9 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE ER 9 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $15.0801 per EA (NDC 00378450093), effective Nov 18, 2026.

How has the price of BUDESONIDE ER 9 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUDESONIDE ER 9 MG TABLET has declined 57.4%. It has been tracked across 311 weekly CMS publications since Dec 9, 2020.

What are the highest and lowest recorded NADAC prices for BUDESONIDE ER 9 MG TABLET?

Since Dec 9, 2020, the NADAC for BUDESONIDE ER 9 MG TABLET has ranged from a low of $11.9909 (May 20, 2026) to a high of $40.3126 (Jan 13, 2021), with a median of $26.4179 per EA.

Are there cheaper alternatives to BUDESONIDE ER 9 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BUDESONIDE ER 9 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BUDESONIDE ER 9 MG TABLET?

BUDESONIDE ER 9 MG TABLET (NDC 00378450093) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.